News

The U.S. Patent and Trademark Office has issued a patent to Imaging Endpoints and Chief Medical Officer Ron Korn for a new breakthrough radiomic evaluation tool which provides a biomarker for predicting tumor aggressiveness in breast cancer patients. It gives…   Read More

New imaging biomarker for predicting tumor aggressiveness. Scottsdale, Arizona – Imaging Endpoints announced today that the U.S. Patent and Trademark Office has issued Patent No. 10,854,338 – “PREDICTING BREAST CANCER RESPONSIVENESS TO HORMONE TREATMENT USING QUANTITATIVE TEXTURAL ANALYSIS” to Imaging…   Read More

Imaging Endpoints is a dynamic organization that’s widely considered the leading imaging CRO (iCRO) within oncology and complex clinical trials. We work passionately toward our mission to Connect Imaging to the CureTM for the benefit of all humanity. Since its…   Read More

AI is making a significant impact for breast cancer detection in mammography and breast tomosynthesis. Read this recent overview of the concepts and developments in the field at https://www.sciencedirect.com/science/article/pii/S1044579X20301358. To learn more about how Imaging Endpoints utilizes AI and other…   Read More

Today is World Pancreatic Cancer Day, where people around the world unite in the fight against one of the world’s deadliest cancers. Imaging Endpoints is the leading imaging CRO in the battle against pancreatic cancer, and our team is passionately…   Read More